Cancer vaccine trial halted early after testing in 17 patients
NCT ID NCT04445064
Summary
This study tested whether a personalized vaccine could help the immune system fight head and neck cancer when given before surgery. It involved 17 patients scheduled for cancer surgery, with some receiving the vaccine and others serving as a comparison group. The trial was terminated early, and researchers were measuring immune responses and tumor changes to see if the approach was safe and showed promise.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LARYNX SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cliniques Universitaires Saint-Luc
Brussels, 1200, Belgium
Conditions
Explore the condition pages connected to this study.